Skip to main content
Top
Published in: Tumor Biology 4/2015

01-04-2015 | Research Article

Contribution of susceptibility locus at HLA class I region and environmental factors to occurrence of nasopharyngeal cancer in Northeast India

Authors: Meena Lakhanpal, Laishram Chandreshwor Singh, Tashnin Rahman, Jagnnath Sharma, M. Madhumangal Singh, Amal Chandra Kataki, Saurabh Verma, Pradeep Singh Chauhan, Y. Mohan Singh, Saima Wajid, Sujala Kapur, Sunita Saxena

Published in: Tumor Biology | Issue 4/2015

Login to get access

Abstract

High incidence of nasopharyngeal carcinoma (NPC) has been reported from China, Southeast Asia and Northeast (NE) region of India. Populations at geographic regions having higher incidence of NPC display human leukocyte antigen (HLA) distribution patterns different from areas having low incidence. The current study has investigated the contribution of environmental risk factors and ethnic variation of microsatellite markers in HLA region for the high incidence of NPC in NE India. Genotyping of HLA region using 33 microsatellite markers by fragment length analysis was done in 220 study subjects (120 NPC patients and 100 healthy controls). Association analysis showed two adjacent microsatellite markers HL003 (allele 121) and D6S2704 (allele 218) in the HLA class I region having association with high risk of NPC while allele 127 of HL003 and allele 255 of D6S2678 conferred a protective effect. The environmental factors mainly use of firewood (odds ratio (OR) = 3.797385, confidence interval (CI) = 1.97–7.30, P < 0), living in mud house (OR = 3.46, CI = 1.19–10.08, P = 0.022) and consumption of alcohol (OR = 2.11, CI = 1.02–4.37, P = 0.043) were found as major risk factors for NPC. Higher-order interaction showed combination of smoked food consumption and firewood use for cooking in multifactor dimensionality reduction (MDR) analysis and interaction of non-firewood users, non-ventilated houses and residence in mud houses in classification and regression tree (CART) analysis as the significant risk factors for NPC. Expression of Epstein–Barr virus (EBV) RNA was found in 92 % (23/25) of NPC cases suggesting its significant role in NPC aetiopathogenesis. This study identified association of NPC with a susceptibility locus in the HLA class I region which has complex interaction with viral DNA and environmental factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fribrog J, Wohlfahrt J, Koch A, Storm H, Olsen R, Melbye M. Cancer susceptibility in nasopharyngeal carcinoma families. Clin Cancer Res. 2005;65(18):856. Fribrog J, Wohlfahrt J, Koch A, Storm H, Olsen R, Melbye M. Cancer susceptibility in nasopharyngeal carcinoma families. Clin Cancer Res. 2005;65(18):856.
2.
go back to reference Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77.CrossRefPubMed Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77.CrossRefPubMed
3.
go back to reference Jia WH, Huang Q-H, Liao J et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in Southern China. BMC Cancer, 2006; 6, article 178. Jia WH, Huang Q-H, Liao J et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in Southern China. BMC Cancer, 2006; 6, article 178.
4.
5.
go back to reference Epedemilogical and Etiological factors associated with Nasopharyngeal carcinoma. ICMR Bulletin 2003; 33, No.9. Epedemilogical and Etiological factors associated with Nasopharyngeal carcinoma. ICMR Bulletin 2003; 33, No.9.
6.
go back to reference Zinyu R, Kumar S, Dutta, LP. Studies on cancer of the nasopharynx in Nagaland, India. Proceedings of the XVI World Congress of Otorinolaryngology and Head and Neck Surgery. T. Sacriston et al. (eds) Kuglar and Ghedini Pubications, Amesterdam; 1990; p1279. Zinyu R, Kumar S, Dutta, LP. Studies on cancer of the nasopharynx in Nagaland, India. Proceedings of the XVI World Congress of Otorinolaryngology and Head and Neck Surgery. T. Sacriston et al. (eds) Kuglar and Ghedini Pubications, Amesterdam; 1990; p1279.
7.
go back to reference Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res. 1974;34:1189–91.PubMed Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res. 1974;34:1189–91.PubMed
9.
go back to reference Jia WH, Qin HD. Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review. Semin Cancer Biol. 2012;22(2):117–26.CrossRefPubMed Jia WH, Qin HD. Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review. Semin Cancer Biol. 2012;22(2):117–26.CrossRefPubMed
10.
go back to reference Guo XC, Scott K, Liu Y, et al. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics. 2006;2(6):365–75.CrossRefPubMedPubMedCentral Guo XC, Scott K, Liu Y, et al. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics. 2006;2(6):365–75.CrossRefPubMedPubMedCentral
11.
go back to reference He ZM, Wang SL, Yuan JH, Chen ZC. Expression of human cytochrome P450 2E1 gene in embryonic nasopharynx, nasopharyngeal cancer cell lines and tissue. Ai Zheng. 2002;21(6):597–600.PubMed He ZM, Wang SL, Yuan JH, Chen ZC. Expression of human cytochrome P450 2E1 gene in embryonic nasopharynx, nasopharyngeal cancer cell lines and tissue. Ai Zheng. 2002;21(6):597–600.PubMed
12.
go back to reference Chen Y, Chan SH. Polymorphism of T-cell receptor genes in nasopharyngeal carcinoma. Int J Cancer. 1994;56(6):830–3.CrossRefPubMed Chen Y, Chan SH. Polymorphism of T-cell receptor genes in nasopharyngeal carcinoma. Int J Cancer. 1994;56(6):830–3.CrossRefPubMed
13.
go back to reference Zhuo X, Cai L, Xiang Z, Li Q, Zhang X. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res. 2009;28:46.CrossRefPubMedPubMedCentral Zhuo X, Cai L, Xiang Z, Li Q, Zhang X. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res. 2009;28:46.CrossRefPubMedPubMedCentral
14.
go back to reference Fan Q, Jia WH, Zhang RH, Yu XJ, Chen LZ, Feng QS, Zeng YX. Correlation of polymeric immunoglobulin receptor gene polymorphisms to susceptibility of nasopharyngeal carcinoma. 2005;24(8):915–8. Fan Q, Jia WH, Zhang RH, Yu XJ, Chen LZ, Feng QS, Zeng YX. Correlation of polymeric immunoglobulin receptor gene polymorphisms to susceptibility of nasopharyngeal carcinoma. 2005;24(8):915–8.
15.
go back to reference Jalbout M, Bouaouina N, Gargouri J, Corbex M, Ben Ahmed S, Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett. 2003;193(1):75–81. Jalbout M, Bouaouina N, Gargouri J, Corbex M, Ben Ahmed S, Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett. 2003;193(1):75–81.
16.
go back to reference Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1100–4.PubMed Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1100–4.PubMed
17.
go back to reference Tsujimura A, Ota M. Katsuyama Y, etal Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum Genet. 2002;110(2):192–7.CrossRefPubMed Tsujimura A, Ota M. Katsuyama Y, etal Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum Genet. 2002;110(2):192–7.CrossRefPubMed
18.
go back to reference Matsuzaka Y, Makino S, Nakajima K, et al. New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens. 2000;56(6):492–500.CrossRefPubMed Matsuzaka Y, Makino S, Nakajima K, et al. New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens. 2000;56(6):492–500.CrossRefPubMed
19.
go back to reference Trachtenberg E, Vinson M, Hayes E, et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens. 2007;70(6):455–63.CrossRefPubMed Trachtenberg E, Vinson M, Hayes E, et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens. 2007;70(6):455–63.CrossRefPubMed
20.
go back to reference Foissac A, Crouau-Roy B, Fauré S, Thomsen M, Cambon-Thomsen A. Microsatellites in the HLA region: on overview. Tissue Antigens. 1997;49(3 Pt 1):197–214.CrossRefPubMed Foissac A, Crouau-Roy B, Fauré S, Thomsen M, Cambon-Thomsen A. Microsatellites in the HLA region: on overview. Tissue Antigens. 1997;49(3 Pt 1):197–214.CrossRefPubMed
21.
go back to reference de Jong MM, Nolte IM, de Vries EG, et al. The HLA class III subregion is responsible for an increased breast cancer risk. Hum Mol Genet. 2003; 15, 12(18), 2311–2319. de Jong MM, Nolte IM, de Vries EG, et al. The HLA class III subregion is responsible for an increased breast cancer risk. Hum Mol Genet. 2003; 15, 12(18), 2311–2319.
22.
go back to reference Zoodsma M, Nolte IM, Schipper M, et al. Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J Med Genet. 2005;42(8):e49.CrossRefPubMedPubMedCentral Zoodsma M, Nolte IM, Schipper M, et al. Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J Med Genet. 2005;42(8):e49.CrossRefPubMedPubMedCentral
23.
go back to reference Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin’s lymphoma. Lancet. 2005; 1,365(9478), 2216–2224. Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin’s lymphoma. Lancet. 2005; 1,365(9478), 2216–2224.
24.
go back to reference Lu CC, Chen JC, Tsai ST, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer. 2005; 10,115(5),742-746. Lu CC, Chen JC, Tsai ST, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer. 2005; 10,115(5),742-746.
25.
go back to reference Sonneveld DJ, Lutke Holzik MF, Nolte IM et al. Testicular carcinoma and HLA Class II genes. Cancer. 2002; 1, 95(9), 1857–1863. Sonneveld DJ, Lutke Holzik MF, Nolte IM et al. Testicular carcinoma and HLA Class II genes. Cancer. 2002; 1, 95(9), 1857–1863.
26.
go back to reference De Jong MM, Niens M, Nolte IM, et al. The human leukocyte antigen region and colorectal cancer risk. Dis Colon Rectum. 2005;48(2):303–6.CrossRefPubMed De Jong MM, Niens M, Nolte IM, et al. The human leukocyte antigen region and colorectal cancer risk. Dis Colon Rectum. 2005;48(2):303–6.CrossRefPubMed
27.
go back to reference Ren ZF, Liu WS, Qin HD, et al. Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong. China Cancer Epidemiol. 2010;34(4):419–24.CrossRefPubMed Ren ZF, Liu WS, Qin HD, et al. Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong. China Cancer Epidemiol. 2010;34(4):419–24.CrossRefPubMed
28.
go back to reference Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. Environmental risk factors for nasopharyngeal carcinoma: a case–control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev. 1992;1(5):345–8.PubMed Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. Environmental risk factors for nasopharyngeal carcinoma: a case–control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev. 1992;1(5):345–8.PubMed
29.
go back to reference Chu EA, Wu JM, Tunkel DE, Ishman SL. Nasopharyngeal carcinoma: the role of the Epstein-Barr virus. Medscape J Med. 2008;10(7):165.PubMedPubMedCentral Chu EA, Wu JM, Tunkel DE, Ishman SL. Nasopharyngeal carcinoma: the role of the Epstein-Barr virus. Medscape J Med. 2008;10(7):165.PubMedPubMedCentral
30.
go back to reference Su WH, Hildesheim A, Chang YS. Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol. 2013;9(3):299. Su WH, Hildesheim A, Chang YS. Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol. 2013;9(3):299.
31.
go back to reference G Niedobitek, N Meru, Henri-Jaques Q. Epstein-Barr virus infection and human malignancies Blackwell Science Ltd. Int J Exp Path. 2001; 82, 149 ± 170 149 G Niedobitek, N Meru, Henri-Jaques Q. Epstein-Barr virus infection and human malignancies Blackwell Science Ltd. Int J Exp Path. 2001; 82, 149 ± 170 149
32.
go back to reference Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization. 1998 Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization. 1998
33.
go back to reference Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature. 1999; 28;401(6756):921–3. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature. 1999; 28;401(6756):921–3.
34.
go back to reference Schneider S, Roessli D, Excofier L. Arlequin: a software for population genetics data analysis, vol. 2.000. Geneva: Genetics and Biometry Lab, Department of Anthropology, University of Geneva; 2000. Schneider S, Roessli D, Excofier L. Arlequin: a software for population genetics data analysis, vol. 2.000. Geneva: Genetics and Biometry Lab, Department of Anthropology, University of Geneva; 2000.
35.
go back to reference Raymond M, Rousset F. An exact test for population differentiation. Evolution. 1995;49:1280–3.CrossRef Raymond M, Rousset F. An exact test for population differentiation. Evolution. 1995;49:1280–3.CrossRef
36.
go back to reference Raymond M, Rousset F. Genepop (version 1.2): population genetics software for exact tests and ecumenicism. J Hered. 1997;86:248–9.CrossRef Raymond M, Rousset F. Genepop (version 1.2): population genetics software for exact tests and ecumenicism. J Hered. 1997;86:248–9.CrossRef
37.
go back to reference Steinberg D. Colla PCART- classification and regression trees. San Diego: Salford Systems; 1997. Steinberg D. Colla PCART- classification and regression trees. San Diego: Salford Systems; 1997.
38.
go back to reference Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19(3):376–82.CrossRefPubMed Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19(3):376–82.CrossRefPubMed
40.
go back to reference Bell MJ, Abbott RJ, Croft NP, Hislop AD, Burrows SR. An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP. J Virol. 2009;83(6):2783–8.CrossRefPubMedPubMedCentral Bell MJ, Abbott RJ, Croft NP, Hislop AD, Burrows SR. An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP. J Virol. 2009;83(6):2783–8.CrossRefPubMedPubMedCentral
41.
go back to reference Moretta A, Biassoni R, Bottino C, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 1997;155:105–17.CrossRefPubMed Moretta A, Biassoni R, Bottino C, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 1997;155:105–17.CrossRefPubMed
42.
go back to reference Browning M, Dunnion D. HLA and cancer: implications for cancer immunotherapy and vaccination. Eur J Immunogenet. 1997;24(4):293–312.CrossRefPubMed Browning M, Dunnion D. HLA and cancer: implications for cancer immunotherapy and vaccination. Eur J Immunogenet. 1997;24(4):293–312.CrossRefPubMed
43.
go back to reference Garrido F, Ruiz-Cabello F, Cabrera T, et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today. 1997;18(2):89–95.CrossRefPubMed Garrido F, Ruiz-Cabello F, Cabrera T, et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today. 1997;18(2):89–95.CrossRefPubMed
44.
go back to reference Pichon L, Hampe A, Giffon T, Carn G, Legall JY, David V. A new non-HLA multigene family associated with the PERB11 family within the MHC class I region. Immunogenetics. 1996;44(4):259–67.CrossRefPubMed Pichon L, Hampe A, Giffon T, Carn G, Legall JY, David V. A new non-HLA multigene family associated with the PERB11 family within the MHC class I region. Immunogenetics. 1996;44(4):259–67.CrossRefPubMed
45.
46.
go back to reference Nisole S, Stoye JP, Saïb A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005;3(10):799–808.CrossRefPubMed Nisole S, Stoye JP, Saïb A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005;3(10):799–808.CrossRefPubMed
47.
go back to reference Hatakeyama, S. TRIM proteins and cancer. Nat Rev Cancer. 2011; 7;11(11):792–804. Hatakeyama, S. TRIM proteins and cancer. Nat Rev Cancer. 2011; 7;11(11):792–804.
48.
go back to reference Keckesova Z, Ylinen LMJ, Towers GJ. The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci USA. 2004;101:10780–5.CrossRefPubMedPubMedCentral Keckesova Z, Ylinen LMJ, Towers GJ. The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci USA. 2004;101:10780–5.CrossRefPubMedPubMedCentral
49.
go back to reference Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A. 2004; 20;101(29):10774–9. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A. 2004; 20;101(29):10774–9.
50.
go back to reference Uchimura S, Iizuka N, Tamesa T, Miyamoto T, Hamamoto Y, Oka M. Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma. Anticancer Res. 2007;27(5A):3323–30.PubMed Uchimura S, Iizuka N, Tamesa T, Miyamoto T, Hamamoto Y, Oka M. Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma. Anticancer Res. 2007;27(5A):3323–30.PubMed
51.
go back to reference Ruan HL, Xu FH, Liu WS, et al. Alcohol and tea consumption in relation to the risk of nasopharyngeal carcinoma in Guangdong. China Front Med China. 2010;4(4):448–56.CrossRefPubMed Ruan HL, Xu FH, Liu WS, et al. Alcohol and tea consumption in relation to the risk of nasopharyngeal carcinoma in Guangdong. China Front Med China. 2010;4(4):448–56.CrossRefPubMed
52.
go back to reference Chen L, Gallicchio L, Boyd-Lindsley K, Tao XG, Robinson KA, Lam TK, et al. Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review. Nutr Cancer. 2009;61(1):1–15.CrossRefPubMedPubMedCentral Chen L, Gallicchio L, Boyd-Lindsley K, Tao XG, Robinson KA, Lam TK, et al. Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review. Nutr Cancer. 2009;61(1):1–15.CrossRefPubMedPubMedCentral
53.
go back to reference Sharma TD, Singh TT, Laishram RS, Sharma LD, Sunita AK, Imchen LT. Nasopharyngeal carcinoma–a clinico-pathological study in a regional cancer centre of northeastern India. Asian Pac J Cancer Prev. 2011;12(6):1583–7.PubMed Sharma TD, Singh TT, Laishram RS, Sharma LD, Sunita AK, Imchen LT. Nasopharyngeal carcinoma–a clinico-pathological study in a regional cancer centre of northeastern India. Asian Pac J Cancer Prev. 2011;12(6):1583–7.PubMed
54.
go back to reference Guo X, Johnson RC, Deng H, et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 2009; 15,124(12):2942–2947. Guo X, Johnson RC, Deng H, et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 2009; 15,124(12):2942–2947.
55.
go back to reference Chelleng PK, Narain K, Das HK, Chetia M, Mahanta J. Risk factors for cancer nasopharynx: a case–control study from Nagaland. India Natl Med J India. 2000;13(1):6–8.PubMed Chelleng PK, Narain K, Das HK, Chetia M, Mahanta J. Risk factors for cancer nasopharynx: a case–control study from Nagaland. India Natl Med J India. 2000;13(1):6–8.PubMed
Metadata
Title
Contribution of susceptibility locus at HLA class I region and environmental factors to occurrence of nasopharyngeal cancer in Northeast India
Authors
Meena Lakhanpal
Laishram Chandreshwor Singh
Tashnin Rahman
Jagnnath Sharma
M. Madhumangal Singh
Amal Chandra Kataki
Saurabh Verma
Pradeep Singh Chauhan
Y. Mohan Singh
Saima Wajid
Sujala Kapur
Sunita Saxena
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2942-5

Other articles of this Issue 4/2015

Tumor Biology 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine